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Abstract
The population tends to consume foods that in addition 
to their nutritional values can offer some benefits to 
their health. There are many epidemiological evidences 
and research studies in animal models suggesting that 
diet plays an important role in breast cancer prevention 
or progression. This review summarized some of the 
relevant researches about nutrition and cancer during 
the last years, especially in breast cancer. The analysis 
of probiotics and fermented products containing lactic 
acid bacteria in cancer prevention and/or treatment was 
especially discussed. It was observed that a balance of 
fatty acids similar to those of traditional Mediterranean 
diet, the consumption of fruits and vegetables, dietary 
fiber intake, vitamin supplementation are, along with 
the intake of probiotic products, the most extensively 
studied by the negative association to breast cancer 
risk. The consumption of probiotics and fermented prod-
ucts containing lactic acid bacteria was associated to 
reduce breast cancer risk in some epidemiological stud-
ies. The use of animal models showed the modulation 
of the host’s immune response as one of the important 
effects associated to the benefices observed with most 
probiotics. However; future assays in human are very 
important before the medical community can accept the 
addition of probiotic or fermented milks containing lactic 
acid bacteria as supplements for cancer patients.
© 2014 Baishideng Publishing Group Inc. All rights reserved.
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Core tip: The population tends to consume foods that 
in addition to their nutritional values can offer some 
benefits to their health. In this sense, there are many 
epidemiological evidences and research studies sug-
gesting that diet plays an important role in breast can-
cer prevention or progression. This review summarized 
some of the relevant researches about nutrition and 
cancer during the last years, especially in breast cancer. 
The analysis of probiotics and fermented products con-
taining lactic acid bacteria in cancer prevention and / or 
treatment was especially discussed.
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to their nutritional values can offer some benefits to their 
health.
The WHO reported that approximately 30% of  can-
cer deaths are due to five behavioral risk factors and diet, 
such as high body mass index, low fruit and vegetable 
intake, lack of  physical activity, tobacco use, alcohol use[1] 
Breast cancer is a type of  tumour in which there are 
many reports about the influence of  nutrition[2,3].
Lactic acid bacteria (LAB) represent a heterogeneous 
group of  microorganisms that are present in the normal 
diet of  many people and also in the gastrointestinal and 
urogenital tract of  animals, and some of  these claimed 
to be probiotics. Probiotics are defined as live microor-
ganisms which when administered in adequate amounts, 
confer a health benefit on the host[4]. These microorgan-
isms and fermented foods containing LAB were growing 
in their popularity due to increasing numbers of  studies 
proving that certain strains present health promoting 
properties, among them the prevention or treatment in 
the early stages of  some types of  cancers[5,6].
The use of  experimental animal models has a number 
of  advantages in that the environmental conditions and 
genetics can be either controlled or defined. The value 
of  the models is the insight they can provide into the 
complex, multi-faceted processes and mechanisms that 
can result in cancer development. In vitro assays are also 
important to understand the mechanisms of  action in-
volved in the LAB or other dietary effects. However, the 
application of  dietary modifications against cancer needs 
to be ultimately tested in human trials.
This review summarizes some of  the relevant re-
searches about nutrition and cancer during the last years, 
especially in breast cancer. The analysis of  probiotics and 
fermented products containing LAB in cancer prevention 
and / or treatment will be discussed separately, with em-
phasis in the possible mechanisms involved. 
NUTRITION AND CANCER
Several studies have been demonstrated a relationship 
(either beneficial or harmful) between diet and develop-
ment of  different types of  cancer[7-9]. High fat diet, fiber 
consumption and vitamins are among dietary habits more 
reported by their association with cancer along with pro-
biotic supplements, that will be discussed in a separately 
section.
Calorie restriction without malnutrition was associ-
ated to cancer prevention[10]. This effect was related to 
the reduction in the activity of  pro-aging pathways, in-
flammation in the pre-cancerous cells, and to the increase 
in the apoptosis of  damaged cells.
Several epidemiological studies have been shown the 
relationship between increase consumption of  high fat 
diet and the risk to develop cancer, such as kidney, stom-
ach, lung, esophagus, colon and breast cancer. Colorectal 
cancer (CRC) is a tumour for which there are many stud-
ies that associate obesity with increased risk, especially 
in men[11]. The exact mechanisms of  this relationship 
are still unknown, but metabolic syndrome, insulin resis-
tance[12], modifications in levels of  adipocytokines[13] seem 
to be implicated. The role of  the microbiota in the main-
tenance of  intestinal homeostasis, and it relationship with 
intestinal inflammation and colon carcinogenesis was also 
extensively studied[14-16].
Dietary fat intake was also related to risk of  ovarian 
cancer. It was suggested that higher intake of  omega-3 
may be protective, whereas high consumption of  trans 
fat may increase risk of  this cancer[17].
The fiber consumption is another important compo-
nent of  the diet that was associated inversely with cancer 
risk, such as CRC[18], nasopharyngeal carcinoma[19], oe-
sophageal cancer[20]. 
The consumption of  vitamins and mineral supple-
ments are commonly used to prevent chronic diseases 
such as cancer. It was demonstrated that vitamin C 
(ascorbate) was selectively toxic to some types of  tumor 
cells[21]. Recently, it was reported a case in which the con-
sumption of  this vitamin decreased chemotherapy asso-
ciated side effects[22]. As regard to vitamin D, Bikle[23] re-
vised its relationship with different cancers and described 
that animal and cellular studies supported a role for vita-
min D in the prevention and treatment of  cancer, but the 
same conclusion was not arrived from clinical studies. 
Folate is essential for DNA synthesis and methylation 
and its role against cancer is controversial, even against 
one type of  cancer, such as for prostate cancer[24]. Some 
studies implicated folates with tumour progression, such 
as the work reported by Dixon et al[25] showing evidences 
that folate intake affects ovarian cancer survival. On 
other hand, the chemopreventive effect of  folic acid was 
evaluated in vivo using rat as model for liver carcinogene-
sis. This effect was observed in association with tributyrin 
and was related to the potential to inhibit tumour angio-
genesis[26]. A recent review and meta-analysis showed that 
dietary folate intake was associated with a decreased risk 
of  esophageal and pancreatic cancer, but not gastric can-
cer[27].
NUTRTION AND BREAST CANCER
There are many epidemiological evidences and research 
studies in human and animals suggesting that diet plays 
an important role in breast cancer prevention or progres-
sion[2,3]. Diet represents one of  the most modifiable risk 
factors for breast cancer[28]. Changes in the dietary pat-
terns are not only related to less risk but also patients di-
agnosed and treated for breast cancer who pursue health-
ier dietary habits can improve their health and survival.
The relationship between obesity and breast cancer 
was reviewed in many articles because the high incidence 
and prevalence of  both diseases. Overweight and obesity 
at the time of  diagnosis were associated with a worse 
prognosis in breast cancer patients[29]. A study in Italy 
showed that a diet high in glycemic load was associated 
with increased breast cancer risk[30].
A systematic review showed that there are some strat-
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egies to prevent weight gain that may decrease the risk 
of  breast cancer or improve cancer outcomes in women 
with breast cancer[31].
de Lorgeril and Salen suggested that a high omega-3 
to omega-6 ratio, such as the case of  traditional Mediter-
ranean diet, reduce the risk of  cancer, especially breast 
cancer[32]. A cohort study of  breast cancer survivors 
showed that intake of  marine fatty acids EPA (eicosap-
entaenoic) plus DHA (Docosahexaenoic) was associated 
with improved prognosis[33]. Omega-3 fatty acid, in par-
ticular EPA and DHA found principally in oily fish have 
been demonstrated to exert anti-angiogenic effects in-
hibiting production of  different angiogenic mediators[34]. 
The beneficial effect of  EPA and DHA intakes was also 
associated by reducing inflammation through different 
mechanisms such as the suppression of  NF-κB, and the 
alteration of  the plasma membrane micro-organization 
(lipid rafts)[35].
Canola oil has also been associated with a reduced risk 
of  breast cancer. The inhibition of  cancer cells in vitro 
and the reduction of  tumour volume in rats with chemi-
cal induced mammary tumour that consumed canola oil 
was reported[36]. It was also suggested that canola oil can 
be used as prenatal nutritional strategies to reduce breast 
cancer risk in humans[37]. This suggestion was based in 
results obtained in vivo using a chemical induced mam-
mary tumour in offspring rats of  canola-fed dams. These 
animals showed significantly decreased tumor volume 
with increased survival rate comparing to the control 
group whose mothers received control diet with soybean 
oil during pregnancy and lactation. 
Diets rich in fruits and vegetables are also implicated 
in breast cancer risk reduction. A meta-analysis includ-
ing fifteen prospective studies that reported decreased 
risk of  breast cancer associated with fruit and vegetable 
intake, showed that high intake of  fruits, and fruits and 
vegetables combined can be associated with reduction in 
risk of  breast cancer[38]. Similar results were obtained in a 
meta-analysis of  prospective studies of  blood concentra-
tions of  carotenoids and breast cancer risk[39]. Carotenoid 
concentrations in blood can be used as biomarkers of  
fruit and vegetable intake and in this sense; the authors 
showed that blood concentrations of  carotenoids were 
strongly associated with reduced breast cancer risk. Re-
cently, an inverse association between citrus fruits intake 
and the risk of  breast cancer was suggested[40].
Dietary fiber intake was also inversely associated with 
breast cancer risk[41]. The ingestion of  dietary phytoestro-
gens may increase risk of  estrogen receptor alpha (ERα)-
positive breast cancer and this effect was associated 
with their estrogenic effects observed in vitro and in vivo. 
The proliferative effect of  soy isoflavones was mainly 
observed in animal models of  tumours. However; para-
doxically, consumption of  phytoestrogens has also been 
associated with reduced risk of  breast cancer[42-46]. This 
controversy with regard to the effect of  soy isoflavones 
on breast cancer risk was analyzed and it was demon-
strated that soy isoflavone phase Ⅱ metabolism differs 
between humans and rodents, and this should be taken in 
count to understand the value of  the use of  these rodents 
for investigate the effects of  isoflavones in humans[47]. 
Epidemiologic data indicate that soy intake is associated 
with a decreased breast cancer risk in Asia. A systematic 
review among women showed the possible protective 
effect of  isoflavones on breast cancer risk[48]. It was also 
demonstrated that soy isoflavone intake was associated 
with lower risk of  recurrence among post-menopausal 
patients with breast cancer and those who were receiving 
adjuvant endocrine therapy[49].
The understandings of  the hormonal and non-hor-
monal mechanisms by which isoflavones can exert the 
beneficial effects were subject of  many researches. The 
chemical structure of  soy isoflavones is similar to that of  
estrogens. They are therefore considered to be possible 
selective estrogen receptor modulators (SERMs), which 
may bind to estrogen receptors and selectively stimulate 
or inhibit estrogen-like action in various tissues[50]. It was 
demonstrated that sera of  adult mice consuming soy iso-
flavone genistein (GEN) or blueberry (BB) polyphenol-
containing diet altered mammosphere formation in vitro 
using receptor-positive and estrogen receptor-negative 
human breast cancer cell lines[51]. Recently, this group 
demonstrated that breast cancer prevention by GEN 
was related to the regulation of  mammary adiposity[52]. 
The cytotoxic action of  GEN against breast cancer cells 
involved mobilization of  endogenous copper ions and 
generation of  reactive oxygen species[53].
Vitamin supplementation is another strategy, as was 
explained above, used to reduce cancer risk. With regard 
breast cancer, there was no found clear evidence of  can-
cer prevention for vitamin supplements[54]. Folates and 
folic acid were evaluated in breast cancer patients and 
also in vivo using animal models, and as was explained, the 
role of  folates is controversial. There are epidemiological 
studies suggesting an inverse association between folate 
status and the risk of  breast cancer[55,56]. Some studies 
have also suggested that with alcohol consumption, folate 
supplementation reduces the risk of  breast cancer[57,58]. 
The beneficial effect associated to folate intake in some 
populations was associated to genetic polymorphisms of  
folate-metabolizing enzyme, methylenetetrahydrofolate 
reductase (MTHFR)[59]. A population-based case-control 
study in Saudi Arabia showed that the MTHFR C677T 
polymorphism may modify the association between di-
etary folate intake and breast cancer risk[60]. Similar results 
were obtained from the Shanghai Breast Cancer Study[61] 
and in a case-control study in the Jiangsu Province of  
China[62]. A recent work suggested that intake of  natural 
folates can be inversely associated with breast cancer risk, 
but this association may vary by race, menopausal status 
or estrogen receptor status[63]. The authors also observed 
an increased risk in European American women with the 
highest intake of  synthetic folate from fortified foods. In 
this sense, a systematic review analyzed the effect of  high 
folate intake post fortification, especially when folic acid 
was used, and demonstrated a higher risk of  breast can-
457 August 10, 2014|Volume 5|Issue 3|WJCO|www.wjgnet.com
Aragón F et al . Diet and breast cancer
different to the intestine due to the existence of  the 
common mucosal immune system. In this sense, after 
intestinal stimulation, both B and T cells can migrate 
from Peyer’s patches to mucosal membranes of  the re-
spiratory, gastrointestinal and genito-urinary tract, as well 
as to exocrine glands such as the lacrimal, salivary, mam-
mary and prostatic glands[91]. The oral administration of  
L. casei CRL 431 to mice induced an immune stimulation 
not only at the intestinal level, but also in bronchus and 
mammary glands[92].
Beneficial effects of  probiotic LAB administration 
were reported for non-intestinal tumors. The antitumor 
activity of  L. casei CRL 431 was studied against a fibro-
sarcoma induced by methylcholantrene in mice. The 
administration of  the probiotic strain inhibited tumor 
growth in a dose-dependent form[93,94], stimulated the im-
mune system with high levels of  macrophage activation 
(the main infiltrative cells in the tumor), high levels of  
TNFα and with a remarkable decrease in tumor volume.
The effect of  LAB or fermented products containing 
these microorganisms in non-intestinal tumours reported 
during the last years (2011-2014) were obtained searching 
the words “probiotc and cancer” in PubMed database. 
It was reported the beneficial effect against cervical 
cancer. A pilot study suggested that probiotic promotes 
the clearance of  HPV-related cytological abnormalities[95]. 
Common vaginal lactobacilli exerted cytotoxic effects on 
cervical tumour cells independently of  pH and lactate[96]. 
L. casei displaying E7 antigen at its surface protected 
mice against human papillomavirus type 16-induced tu-
mours[97]. 
As regard hepatocarcinoma, the administration of  
probiotic fermented milk containing L. rhamnosus GG 
and, L. casei strain Shirota with chlorophyllin reduced 
liver pre-carcinogenic events in rat AFB1 induced liver 
carcinogenesis. This effect was attributed to an increased 
antioxidant status and decreased expression of  onco-
genes[98].
The beneficial effects of  LAB were also reported in 
animal models of  oral cancer[99], and skin carcinogen-
esis[100].
PROBIOTICS AND BREAST CANCER
Breast cancer is another tumour in which there are re-
ports about the beneficial effects of  probiotic administra-
tion. Many reports analyzed, as was explained above, the 
association of  soy based products and especially soy iso-
flavones with breast cancer risk. In this context, soy iso-
flavone ingestion was studied accompanied with the co-
administration of  probiotic bacteria, and it was observed 
that high concentrations of  probiotics may alter the me-
tabolism of  isoflavones[101]. Recently, the consumption of  
beverages containing L. casei Shirota and soy isoflavone 
was inversely associated with the incidence of  breast can-
cer in Japanese women when they were consumed regu-
larly since adolescence[102]. The cooperative prevention 
mechanism of  soymilk and L. casei Shirota was evaluated 
cer in these populations[64]. The authors showed the need 
to be cautious with high intakes of  folic acid, especially in 
countries with mandatory food fortification, as Chile. 
Animal models were used to understand the mecha-
nisms by which folates and folic acid exert their effects, 
especially in breast cancer patients. Mammary tumors 
were chemically induced in rats and then, the animals 
received a diet containing different levels of  folic acid[65]. 
Folic acid supplementation was associated with signifi-
cantly higher volume of  mammary tumors and increased 
expression of  BAX, PARP, and HER.
Riboflavin intake was also analyzed and an inverse as-
sociation with breast cancer risk was documented[66].
Selenium (Se) is an essential micronutrient having 
high anticancer properties in different animal models[67,68]. 
As regard to breast cancer, it was demonstrated, using an 
animal model, that organic Se supplementation may re-
duce breast cancer metastasis, while selenite exacerbated 
it[69].
Another dietary component (even though is minor in 
our diet) that was reported as effective against cancer is 
the inorganic sulfur. It was showed that inorganic sulfur 
significantly decreased proliferation of  MDA-MB-231 
human breast[70]. This effect was due to reduction of  
ErbB2 and ErbB3 protein and mRNA expression, affect-
ing the he ErbB-Akt pathway. Previously, it was reported 
that inorganic sulfur reduced cancer cell motility and 
invasion by inhibiting activity and mRNA expression of  
matrix metalloproteases (MMP-2 and MMP-9)[71].
PROBIOTICS AND CANCER
Probiotic microorganisms and fermented foods con-
taining LAB have been growing in popularity due to 
increasing numbers of  studies proving that certain strains 
present health promoting properties, among them the 
prevention or treatment in the early stages of  some types 
of  cancers[5,6,72].
The effects of  probiotics and fermented products 
on intestinal disorders have been the most extensively 
studied considering that these microorganisms enter the 
organism orally and can positively modulate the intestinal 
microbiota involved in many of  these disorders. The ben-
efits of  probiotics on the gut immune system in the pre-
vention of  cancer has also been previously described[73,74]. 
There are many different mechanisms by which probiot-
ics and fermented products containing viable LAB may 
lower the risk of  colon cancer; among them, the modula-
tion of  the intestinal microbiota[75-80], the inactivation of  
carcinogenic compound[81-83], anti-oxidant effects[84-86], 
and the modulations of  the host’s immune response[87-89]. 
Recently, the administration of  probiotic Dahi contain-
ing Lactobacillus (L.) acidophilus LaVK2 and Bifidobacterium 
bifidum BbVK3 alone or in combination of  piroxicam 
showed anti-neoplastic and anti-proliferative activities in 
a model of  DMH-induced CRC in rats[90].
It was also demonstrated that oral administration of  
probiotic microorganisms can influence mucosal sites 
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using a rat carcinogenic model. It was observed that soy-
milk prevented the development of  mammary tumors 
and that L. casei Shirota suppressed tumor growth[103].
In the West diet, fermented milks are more common 
as probiotic foods than soy based products. Milks fer-
mented by different LAB and bifidobacteria strains (B. in-
fantis, B. bifidum, B. animalis, L. acidophilus and L. paracasei) 
were evaluated in vitro, and the inhibition of  the growth 
of  a breast cancer cell line was reported[104]. Other stud-
ies performed in humans, showed a negative association 
between yogurt consumption and breast cancer develop-
ment[105]. van’t Veer et al[106] showed similar results in The 
Netherlands, and suggested that these effects would be 
related to changes in the intestinal microbiota (which 
could alter the metabolism of  estrogen) and to the mod-
ulation on the immune system.
In addition to containing LAB, fermented milks can 
possess non-bacterial components produced during 
fermentation that may contribute to their anti-tumor 
activities[107]. Thus, cultured dairy products can be pro-
posed to inhibit the growth of  many types of  cancers, 
including breast tumors. In this context, milk fermented 
by L. helveticus R389 (a strain with high proteolytic activ-
ity) was studied comparatively with the milk fermented 
by a proteolytic deficient mutant, and both were able to 
delay tumour growth in an experimental breast cancer 
model using BALB/c mice[108,109]. This effect was related 
to the immunoregulatory capacity of  the fermented milks 
that decreased IL-6 levels, modulating the relationship 
between immune and endocrine systems. The important 
increase of  IL-10 in mice fed with milk fermented by L. 
helveticus R389 could explain the difference between both 
fermented milks, attributed principally to the components 
released into the milk after the fermentation with the 
proteolytic strain, where the regulation of  the immune 
response was observed in serum, mammary gland and 
also in the tumour infiltrating immune cells. 
Kefir was another fermented product also evaluated in 
a breast cancer model in mice. Kefir and its cell-free frac-
tion (KF) possess several substances that can exert ben-
eficial effects on the immune system and prevent certain 
types of  cancer[110]. It was observed that mice receiving 
2 d cyclical feeding with whole kefir diminished tumour 
growth, and the same cyclical feeding with KF showed 
the most significant delay of  the tumour growth[111]. This 
effect was related principally to a decrease in IL-6. KF 
caused not only a decrease of  this cytokine but also a 
regulatory response with increased levels of  IL-10 in all 
the samples studied. The results also demonstrated that 
the most important effect in this tumour model was due 
to substances released during milk fermentation (and not 
the microorganisms themselves)[112].
Table 1 summarizes the effects reported for dif-
ferent LAB against breast cancer during the last years 
(2012-2014).
It was reported that L. acidophilus isolated from tradi-
tional home-made yogurt and also from neonatal stool 
induced a significant decrease in breast tumour growth 
pattern using a mouse model[113]. This effect was associ-
ated to the alteration of  cytokine production into a Th1 
protective pattern. 
L. casei spp. casei ATCC 39392 was also analyzed in 
a model of  invasive ductal carcinoma in mice, and its 
administration decreased the growth rate of  tumor and 
prolonged the survival of  the animals. This effect was 
associated to the improvement of  the host immune re-
sponse by inducing Th1 cytokine profile and natural killer 
cells[114].
The administration of  selenium nanoparticle-enriched 
L. plantarum induced an efficient immune response in 4T1 
breast cancer bearing mice. This effect was caused by 
the elevation of  the pro-inflammatory cytokines IFN-γ, 
TNF-α and IL-2 levels and increased NK cell activity[115].
The importance of  the stimulation of  host immune 
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Table 1  Examples of breast cancer animal models that have demonstrated the beneficial effects of lactic acid bacteria
Model                    Results              Mechanisms                LAB Ref.
4T1 tumour bearing mice Significant decrease of tumour growth Modulation of the host’s immune 
response
L. acidophilus isolated from 
traditional home-made yogurt and 
from neonatal stool
[113]
Mice bearing invasive 
ductal carcinoma
Decrease of tumour growth rate and 
prolongation of mice survival 
Modulation of the host’s immune 
response
L. casei spp. casei ATCC 39392 [114]
4T1 breast cancer bearing 
mice
Tumor volumes of mice treated with Se 
nanoparticle-enriched probiotic were 
decreased and their survival rate increased 
compared to mice that received probiotic 
alone or control mice.
Modulation of the host’s immune 
response




Swiss mice fed a 
Westernized chow and  
FVB strain erbB2 (HER2) 
mutant mice
Inhibition of mammary neoplasia in both 
models.
LAB triggered CD4+CD25+ 




4T1 breast cancer bearing 
mice
Decrease of tumour growth in mice fed 
preventively with LAB and also in mice 
fed probiotic after tumour detection
Modulation of the host’s immune 
response and decrease of tumour 
angiogenesis
L. casei CRL 431 [117]
LAB: Lactic acid bacteria.
Aragón F et al . Diet and breast cancer
cells by LAB and their beneficial effect against mammary 
carcinoma was analyzed using two mice models[116]. In 
one model, mice were fed a Westernized chow increasing 
risk for development of  mammary tumors. The other 
model consisted of  FVB strain erbB2 (HER2) mutant 
mice, genetically susceptible to mammary tumors. Ani-
mals received L. reuteri ATCC-PTA-6475 in drinking 
water. It was observed that LAB oral supplementation 
inhibited features of  mammary neoplasia in both models. 
The protective mechanism was associated to triggered 
CD4+CD25+ lymphocytes because when they were iso-
lated and transplanted into other subjects conferred anti-
cancer protection in the cell recipient animals. 
Recently, our research group evaluated the effect of  
milk fermented by the probiotic bacterium L. casei CRL 
431 on a murine breast cancer model. It was observed 
that the administration of  this probiotic fermented milk 
stimulated the immune response against this breast tu-
mour, avoiding or delaying its growth when it was pre-
ventively administrated and also when the administration 
started after tumour cells injection[117].
CONCLUSION
There are many epidemiological evidences and research 
studies in animal models suggesting that diet plays an im-
portant role in breast cancer prevention or progression. 
A balance of  fatty acids similar to those of  traditional 
Mediterranean diet, the consumption of  fruits and veg-
etables, dietary fiber intake, vitamin supplementation are, 
along with probiotic products, the most extensively stud-
ied. Although controversial data about isoflavones, epi-
demiological studies showed that the intake of  soy based 
products in Asia was associated with decrease of  breast 
cancer risk. 
Probiotics and fermented products containing LAB 
have awakened the interest of  many researches related 
to cancer and especially with breast cancer. Some epide-
miological studies showed negative association between 
the consumption of  these products and breast cancer 
development. Animal models were used to understand 
the possible mechanisms by which probiotic can exert 
the beneficial effects, and the modulation of  the host’s 
immune response was associated to the effects observed 
with most probiotics. 
 However, there are not enough human trials where 
the application of  probiotics as biotherapeutics against 
breast cancer was tested. These assays are very important 
before the medical community can accept the addition of  
probiotic or fermented milks containing LAB as supple-
ments for cancer patients.
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